1/25/2022: This blog has been updated to reflect new approval and authorization from the FDA for the antiviral drug remdesivir. The best way to fight COVID-19 is to avoid getting it in the first place. That means wearing a well-fitting mask, keeping gatherings small and outdoors if possible and getting vaccinated (including a booster dose if eligible.) But the […]
This week, the Food and Drug Administration (FDA) authorized two oral antiviral treatments for COVID-19 disease.
Today, an expert panel of the Food and Drug Administration (FDA) endorsed the use of the Merck antiviral drug molnupiravir for treatment of symptomatic COVID-19 in test-confirmed patients with high risk conditions. The FDA has not yet authorized the treatment.